MedTrace Logo

Air Pollution and Children With Cystic Fibrosis

NCT03853629 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2020-03-10

No results posted yet for this study

Summary

1. To determine personal exposure to air pollution in children with cystic fibrosis;
2. To determine airway macrophage uptake of inhaled particulate matter in cystic fibrosis children;
3. To establish whether prostaglandin E2 affects particulate matter removal in airway.

Conditions

Interventions

OTHER

None. Not applicable

None. Not applicable

Sponsors & Collaborators

  • Queen Mary University of London

    lead OTHER

Principal Investigators

  • Jonathan Grigg · Queen Mary University of London

Eligibility

Min Age
1 Year
Max Age
17 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-15
Primary Completion
2020-01-30
Completion
2020-01-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03853629 on ClinicalTrials.gov